Oleylethanolamide activates Ras-Erk pathway and improves myocardial function in doxorubicin-induced heart failure

Endocrinology

Volumn 147, Issue 2, 2006, Pages 827-834

  Su, Hou Fen ^a   Samsamshariat, Ahmad ^a   Fu, Jin ^b   Shan, Yue Xin ^a   Chen, Yung Hsiang ^a   Piomelli, Daniele ^b   Wang, Ping H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FATTY ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; OLEYLETHANOLAMIDE; RAF PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL CULTURE; CONTROLLED STUDY; DIASTOLE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; EXPERIMENTAL MODEL; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE REMODELING; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SURVIVAL; SYSTOLE;

ANALYSIS OF VARIANCE; ANIMALS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DOXORUBICIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEART DISEASES; MALE; MYOCYTES, CARDIAC; OLEIC ACIDS; RAS PROTEINS; RATS; RECEPTOR, ERBB-2; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 30944458055     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1098     Document Type: Article

References (22)

1. Braunwald E, Bristow MR (2001) Congestive heart failure: fifty years of progress. Circulation 102(Suppl IV):IV-14-IV-23
2. Wang PH 2001 Roads to survival: insulin-like growth factor-1 signaling pathways in cardiac muscle. Circ Res 88:552-554
3. Bishopric NH, Andreka P, Slepak T, Webster KA 2001 Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 1:141-150
4. Anversa P 2000 Myocyte death in the pathological heart. Circ Res 86:121-124
5. Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D 2001 An anorexic lipid mediator regulated by feeding. Nature 414:209-212
6. Giuffrida A, Rodriguez de Fonseca F, Piomelli D 2000 Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 280:87-93
7. Epps DE, Natarajan V, Schmid PC, Schmid, HO 1980 Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta 618:420-430
8. Epps DE, Cardin AD 1987 The interaction of N-oleylethanolamine with phospholipid bilayers. Biochim Biophys Acta 903:533-541
9. Yang B, Larson DF, Watson R 1999 Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. Am J Physiol 277:H1906-H1913
10. Lee W, Chen J, Ting C, Ishiwata T, Lin S, Korc M, Wang PH 1999 Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in established canine cardiomyopathy. Endocrinology 140:4831-4840
11. Wu W, Lee W, Wu Y, Chen D, Liu T, Sharma PM, Wang PH 2000 Expression of constitutively active phosphatidylinositol 3 kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J Biol Chem 275:40113-40119
12. Wang L, Ma W, Markovich R, Markovich R, Chen J, Wang PH 1998 Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res 83:516-522
13. Wood KW, Sarnecki C, Roberts TM, Blenis J 1992 Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68:1041-1050
14. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Chen LB 1991 Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88:3671-3675
15. Shan Y, Liu T, Su H, Samsamshariat A, Mestril R, Wang PH 2003 Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J Mol Cell Cardiol 35:1135-1143.
16. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D 2003 Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature 425:90-93
17. Abe J, Baines CP, Berk BC 2000 Role of mitogen-activated protein kinases in ischemia and reperfusion injury: the good and the bad. Circ Res 86:607-609
18. Liu T, Lai H, Wu W, Chinn S, Wang PH 2001 Developing a strategy to define the effects of insulin-like growth factor-1 on gene expression profile in cardiomyocytes. Circ Res 88:1231-1238
19. Leahy DJ 2004 Structure and function of the epidermal growth factor (EGF/ErbB) family of receptors. Adv Protein Chem 68:1-27
20. Holbro T, Hynes NE 2004 ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44:195-217
21. Kass DA, Beyer R 1991 Evaluation of contractile state by maximal ventricular power divided by the square of end-diastolic volume. Circulation 84:1698-1708
22. Segers P, Stergiopulos N, Westerhof N 2002 Relation of effective arterial elastance to arterial system properties. Am J Physiol Heart Circ Physiol 282:H1041-H1046